Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis

Abstract Background Current strategies that target cytokines (e.g., tumor necrosis factor (TNF)-α), or signaling molecules (e.g., Janus kinase (JAK)) have advanced the management for allergies and autoimmune diseases. Nevertheless, the molecular mechanism that underpins its clinical efficacy have la...

Full description

Saved in:
Bibliographic Details
Main Authors: Haruka Tsuchiya (Author), Mineto Ota (Author), Haruka Takahashi (Author), Hiroaki Hatano (Author), Megumi Ogawa (Author), Sotaro Nakajima (Author), Risa Yoshihara (Author), Tomohisa Okamura (Author), Shuji Sumitomo (Author), Keishi Fujio (Author)
Format: Book
Published: BMC, 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items